Prevention

Search documents
Bouncing back better | Taline El Hajj | TEDxISL Qatar Youth
TEDx Talks· 2025-07-01 15:33
[Music] Okay. Hi, my name is Tian and if there was ever an Olympic event for getting injured, I would probably hold the record for the most gold medals. Ever.Ask anyone who knows me. Seriously, the amount of money spent on Kape alone can probably single-handedly solve world hunger. Well, not really, but it's bad enough that I got a certificate for it from my dance teacher at a team dinner.It was guess the person style, and everyone, including the parents, instantly pointed at me. For me, this battle with in ...
Honeywell Makes Strategic Tuck-in Acquisition of Li-ion Tamer to Bolster Fire Detection Technologies, Further Strengthening Building Automation Portfolio
Prnewswire· 2025-07-01 11:45
Core Insights - Honeywell has acquired Nexceris' Li-ion Tamer business, enhancing its fire life safety technologies in the Building Automation segment and addressing lithium-ion battery system safety [1][4] - The acquisition is expected to be immediately accretive to Honeywell's financials and positions the company as a leader in early gas detection and battery fire prevention [1][4] Industry Trends - Demand for lithium-ion batteries is projected to grow over 30% annually through 2030, exceeding $400 billion, making battery safety solutions increasingly critical across various sectors [2] - The risk of fire associated with lithium-ion batteries is rising alongside their usage in data centers, electric vehicle infrastructure, and grid-scale energy storage [4] Technology and Product Details - Li-ion Tamer utilizes early warning technology to detect battery off-gassing, providing up to 30 minutes of advance warning before a potential battery fire [3] - The product portfolio includes over 30 global patents and is trusted by leading battery OEMs worldwide [4][7] Strategic Actions - This acquisition follows Honeywell's planned spin-offs of its Aerospace Technologies and Solstice Advanced Materials businesses, aimed at creating three publicly listed industry leaders with distinct strategies [5] - Since December 2023, Honeywell has engaged in strategic actions totaling $13.5 billion in accretive acquisitions to drive organic growth and simplify its portfolio [5]
Trust Stamp Partners with Neural Payments to Bring Innovative ID Security to the $3.2 Trillion P2P Payment Sector
Globenewswire· 2025-06-30 13:30
With 8% of all banking customers saying they’ve been victimized by a P2P scam in the last 12 months, Trust Stamp and Neural Payments partner to decrease the risk of fraud and make banks and their customers more secure Atlanta, GA, June 30, 2025 (GLOBE NEWSWIRE) -- Trust Stamp (Nasdaq: IDAI) today announced a partnership with Neural Payments for the integration of Trust Stamp’s low-code Orchestration Platform. Neural Payments provides banks and credit unions with real-time person-to-person (P2P) payments, ad ...
Chicago Tops Orkin's 2025 Bed Bug Cities List Again as Unexpected Cities Climb the Ranks
Prnewswire· 2025-06-30 10:05
Newcomers like Hartford and Peoria shake up this year's list as travel season threatens to spread infestationsATLANTA, June 30, 2025 /PRNewswire/ -- Hartford, Connecticut made the biggest leap in Orkin's 2025 Top 50 Bed Bug Cities List, debuting at No. 35 after jumping an unprecedented 48 spots – indicating a significant increase in bed bug activity. In contrast, Charlotte (no. 31), Philadelphia (no. 24) and New York (no. 15) all saw significant drops, suggesting fewer reported bed bug infestations compared ...
Invivyd Announces Positive Full Phase 1/2 Clinical Data for VYD2311, a Next Generation COVID-19 Monoclonal Antibody for Potential Use as a Non-Vaccine Preventative and for Treatment of Active Infection
Globenewswire· 2025-06-26 11:01
Attractive safety profile demonstrated across all dosing cohorts and routes of administration (IV, SC, and IM); all reported adverse events (AEs) deemed unrelated or classified as mild to moderate and largely related to injection site and infusion reactions with no serious or severe adverse events observedFollowing a single dose, serum concentrations of VYD2311 remained high at six months with an observed half-life of the IM dose route having the longest duration at 76.0 (CI: 68.5 – 90.7) days Comprehensive ...
NSC Invests $300,000 in Next-Generation Solutions for Safer Workplaces
Prnewswire· 2025-06-25 19:02
Core Insights - The National Safety Council (NSC) awarded $300,000 in grants for the 2025-2026 Research to Solutions (R2S) and MSD Solutions Pilot programs, totaling nearly $850,000 invested in musculoskeletal disorders (MSDs) prevention over three years [1][2] Group 1: Grant Programs - The grants support academic research and workplace pilot programs through the NSC MSD Solutions Lab, which was established in 2021 with funding from Amazon [2][6] - The R2S grant provides up to $50,000 for academic institutions to explore innovative MSD interventions, focusing on areas like emerging technologies and total worker wellbeing [4][5] - The MSD Solutions Pilot Grant offers $20,000 to trial safety innovations through partnerships between MSD Pledge members and technology providers [5][7] Group 2: Awardees and Projects - University of Waterloo will utilize innovative MSD risk assessment tools leveraging data from emerging technologies [7] - Auburn University plans to test a new plant-layout organizational tool for MSD control [7] - Texas Tech University will assess 3D printed head and neck rests to reduce discomfort during overhead work [7] - George Mason University aims to develop smartphone computer vision technology for real-time movement assessment to prevent MSDs in emergency responders [7] - Cargill will collaborate with MākuSafe to explore technology for risk profiling and early hazard identification [7] - Northwell will validate the benefits of a "surgeon exoskeleton" in reducing upper limb strain during complex surgical procedures [7]
Intellicheck (IDN) Earnings Call Presentation
2025-06-25 14:03
May 21, 2025 NASDAQ: IDN This presentation contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Although the forward-looking statements in this presentation reflect the good faith judgment of management, forward-looking statements are inherently subject to known and unknown risks and uncertainties that may cause actual results to be materially different from those discussed in th ...
Accelerating Child Exploitation Investigations: Cellebrite Integrates Data from the National Center for Missing and Exploited Children (NCMEC)
GlobeNewswire News Room· 2025-06-24 20:01
TYSONS CORNER, Va., June 24, 2025 (GLOBE NEWSWIRE) -- Cellebrite (NASDAQ: CLBT), a global leader in premier Digital Investigative solutions for the public and private sectors, today announced the expansion of its relationship with the National Center for Missing and Exploited Children (NCMEC) that will help speed up investigations involving crimes against children. NCMEC’s CyberTipline hash value list is now integrated within Cellebrite’s flagship digital forensics software, Cellebrite Inseyets, allowing pu ...
CHMP Backs NVO's Ozempic EU Label Update for Cardiovascular Indication
ZACKS· 2025-06-24 17:01
Key Takeaways CHMP recommends updating Ozempic's EU label based on positive STRIDE PAD outcomes in T2D patients. Ozempic showed improved walking capacity in patients with T2D and PAD in the late-stage STRIDE study. NVO expects EC approval of the PAD label update within two months; FDA review is underway in the U.S.Novo Nordisk (NVO) announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion recommending that Ozempic’s (once-weekly se ...
Gilead Sciences CEO Daniel O'Day on HIV prevention injection approval
CNBC Television· 2025-06-23 14:54
What what is this latest injectable. Why is it better. It's a milestone moment, Becky, in in the history of HIV.Yes. Tuggo is is potentially the best tool we've had yet and and a number of great tools that could potentially end the epidemic. And the reason why is this is a first of its kind.Um medicine for preventing HIV that's given only twice a year. Uh and in clinical trials, it provided almost 100% protection against HIV, which is really unheard of. So, it's a it's one of the most important scientific b ...